An American gene sequencing company is working towards a universal blood test to identify early-stage cancers in people with no symptoms of the disease. San Diego-based Illumina Inc. is forming a new company, called Grail, with more than AED 350 million of finance. Microsoft’s Bill Gates and Jeff Bezos, founder of Amazon.com are two of the high profile investors.